
Reset all filters
01 6Novo Nordisk Canada Inc.
Reset all filters
01 22264243
02 22468374
03 22545034
Reset all filters
01 3LIRAGLUTIDE
02 3Liraglutide
Reset all filters
01 3SOLUTION
02 3multi dose pen -injector
Reset all filters
01 42017-08-22
02 22024-11-18
Patent Expiration Date : 2017-08-22
Date Granted : 2010-12-21
Brand Name : VICTOZA
Patent Number : 2468374
Filing Date : 1997-08-22
Strength per Unit : 6 mg / ml
Dosage Form : multi dose pen -injector
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2017-08-22
Date Granted : 2010-12-21
Patent Expiration Date : 2024-11-18
Date Granted : 2013-03-05
Brand Name : VICTOZA
Patent Number : 2545034
Filing Date : 2004-11-18
Strength per Unit : 6 mg / ml
Dosage Form : multi dose pen -injector
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2024-11-18
Date Granted : 2013-03-05
Patent Expiration Date : 2017-08-22
Date Granted : 2004-10-05
Brand Name : VICTOZA
Patent Number : 2264243
Filing Date : 1997-08-22
Strength per Unit : 6 mg / ml
Dosage Form : multi dose pen -injector
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2017-08-22
Date Granted : 2004-10-05
Patent Expiration Date : 2017-08-22
Date Granted : 2004-10-05
Brand Name : SAXENDA?
Patent Number : 2264243
Filing Date : 1997-08-22
Strength per Unit : 6 mg / ml
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2017-08-22
Date Granted : 2004-10-05
Patent Expiration Date : 2017-08-22
Date Granted : 2010-12-21
Brand Name : SAXENDA?
Patent Number : 2468374
Filing Date : 1997-08-22
Strength per Unit : 6 mg / ml
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2017-08-22
Date Granted : 2010-12-21
Patent Expiration Date : 2024-11-18
Date Granted : 2013-03-05
Brand Name : SAXENDA?
Patent Number : 2545034
Filing Date : 2004-11-18
Strength per Unit : 6 mg / ml
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2024-11-18
Date Granted : 2013-03-05